Bone Biologics (NASDAQ:BBLGW) Stock Price Down 25.9% – Time to Sell?

Bone Biologics Co. (NASDAQ:BBLGW)’s share price dropped 25.9% during trading on Monday . The company traded as low as $20.00 and last traded at $20.00. Approximately 127 shares changed hands during mid-day trading, a decline of 94% from the average daily volume of 2,049 shares. The stock had previously closed at $27.00.

Bone Biologics Trading Down 25.9%

The company has a 50-day moving average of $22.97 and a two-hundred day moving average of $17.43.

About Bone Biologics

Bone Biologics, Inc is a clinical-stage biopharmaceutical company focused on developing protein-based therapeutics designed to promote bone healing and regeneration in acute and chronic orthopedic conditions. Its proprietary platform combines key osteogenic growth factors with engineered delivery matrices to support repair in complex fractures, spinal fusion procedures and non-union bone injuries. By targeting the biology of bone formation, the company aims to overcome limitations associated with autografts, allografts and synthetic implants.

The company’s lead candidate is advancing through preclinical evaluation, with studies assessing efficacy in animal models of fracture repair and spinal arthrodesis.